Insilico Medicine is the first biotech company to integrate advanced AI chat functionality based on recent advances in large language models into its AI drug discovery platform. The new feature, “ChatPandaGPT,” enables researchers to have natural language conversations with the platform and efficiently navigate and analyze large datasets, facilitating the discovery of potential therapeutic targets and biomarkers in a more efficient manner.

Learn more: https://www.eurekalert.org/news-relea...